Earnings Insights · CME · Q3 FY2026

CME Group Q3 2026 Earnings: Record Revenue as Broad-Based Trading Growth Expands Margins

By AlgovestIQ ResearchPublished

Share

Read CME Group’s results announcement (Form 8-K, filed Oct 21, 2026)

Key earnings findings

CME (CME) Q3 FY2026 · results discussed on the earnings call · Form 8-K filed

  1. CME reported Q3 FY2026 revenue of $1.74B against the $1.71B analyst estimate, a 1.3% beat, and EPS of $3.02 against the $2.99 analyst estimate, a 1.0% beat.
  2. CME closed at $295.79 on Oct 21, 2026, up 0.2% from $295.31 on Oct 20, 2026, the last close before the results were released.
  3. CME Group reported third-quarter revenue of $1.737B, up 13% year over year, and diluted GAAP EPS of $2.89, up from $2.49.

Sources: CME Group results announcement (SEC), the Q3 FY2026 earnings call, and AlgovestIQ reported-results and market data. All references

Did CME beat earnings expectations?

Actual
Estimate
Surprise
Revenue
$1.74B
$1.71B
+1.3%
EPS
$3.02
$2.99
+1.0%
  • EPS has beaten the estimate in 6 of the most recent reported quarters.
  • Revenue surprise across the last 8 reported quarters has ranged from -0.2% to 1.4%.

Reported figures against analyst estimates, compiled from AlgovestIQ data.

CME Group reported third-quarter revenue of $1.737B, up 13% year over year, and diluted GAAP EPS of $2.89, up from $2.49. Adjusted diluted EPS rose 13% to $3.02 as trading activity increased across all six asset classes and market data revenue reached a quarterly record.

The quarter reinforced CME’s operating leverage: revenue grew faster than expenses despite higher licensing costs tied to equity-index activity. The central question is whether elevated volatility and risk-management demand can sustain volume growth after a strong year-to-date run, while newer products, clearing initiatives and cloud investments broaden the company’s longer-term opportunity set.

Earnings Snapshot

MetricReportedChange
Total revenue$1.737BUp 13% year over year
Clearing and transaction fee revenue$1.378BUp 12%
Market data and information services revenue$243.1MUp 20%
Other revenue$116.1MUp 8%
Operating income$1.141BUp 17%
Adjusted operating income$1.206BUp 15%
Net income$1.037BUp 14%
Adjusted net income$1.084BUp 11%
Diluted GAAP EPS$2.89Up 16%
Adjusted diluted EPS$3.02Up 13%
Average daily volume29.4M contractsUp 16%
Average rate per contract$0.679Down from $0.702
Non-U.S. average daily volume9.0M contractsUp 22%
Quarter-end open interest128M contractsRecord for a September quarter
Cash and cash equivalents$2.2BDown from $4.4B at Dec. 31, 2025
Debt$3.4BEssentially unchanged from year-end

The Bigger Story

CME’s quarter was driven by broad-based participation rather than a single market or product. Average daily volume rose 16%, with double-digit year-over-year gains in interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals.

That breadth matters because CME’s core earnings model depends on trading activity across multiple asset classes, which can offset softness in any one market. Interest-rate products remained the largest contributor at 15.1M contracts per day, while equity-index volume increased 23% to 7.7M contracts per day.

The company also continued to build adjacent growth platforms. It is preparing to launch CME Securities Clearing on Dec. 7 ahead of the Treasury clearing mandate, while its Treasury Link cash-futures spread-trading functionality is now in client testing. Those initiatives are strategically relevant because they could deepen CME’s position in rates and clearing rather than merely add new listed contracts.

Revenue and Operating Performance

Clearing and transaction fee revenue increased 12% to $1.378B, reflecting substantially higher contract volumes. The increase came despite average revenue per contract declining to $0.679 from $0.702 a year earlier, indicating that volume growth, rather than improved monetization, was the primary driver of transaction revenue.

Interest-rate average daily volume rose to 15.1M contracts from 13.4M a year earlier. Equity-index volume grew to 7.7M contracts from 6.3M, while foreign exchange increased to 988,000 contracts from 834,000. Energy volume rose to 2.7M contracts from 2.3M, agricultural volume reached 2.0M contracts, and metals volume increased to 935,000 contracts.

International activity was another source of growth. Non-U.S. volume reached a third-quarter record of 9.0M contracts per day, up 22%. EMEA volume increased 20% to 6.5M contracts per day, while APAC volume rose 28% to 2.1M. Management cited particularly strong international growth in energy, agricultural products and equity indexes.

Market data revenue was a notable contributor, increasing 20% to a record $243.1M. Management said growth reflected a mix of professional subscribers, retail and simulated-trading platforms, data-feed demand, software revenue and pricing changes. The result included $4.7M of audit recoveries and catch-up payments for prior-period usage, which contributed to the quarter but should not be treated as recurring growth.

The market data business has now posted 34 consecutive quarters of year-over-year revenue growth. More than half of that revenue comes from outside the U.S., giving CME another international avenue beyond transaction fees.

Profitability and Margins

GAAP operating income increased 17% to $1.141B, outpacing the 13% increase in revenue. GAAP operating margin expanded to approximately 65.7% from 63.3% a year earlier.

On an adjusted basis, operating income rose 15% to $1.206B, producing a 69.4% adjusted operating margin, up from roughly 68.4% in the prior-year period. Adjusted expenses increased 9% to $531.8M, slower than revenue growth.

The cost picture was mixed. Total GAAP expenses rose 5% to $595.9M. Licensing and other fee agreements increased 28% to $104.2M, primarily reflecting stronger equity-index activity, where index licensing costs rise with volume. Technology expense increased 13% to $80.9M, while compensation and benefits declined modestly to $234.3M.

Adjusted net income increased 11% to $1.084B, and adjusted diluted EPS rose to $3.02 from $2.68. The gap between GAAP and adjusted results primarily reflected amortization of purchased intangibles, restructuring and severance costs, foreign-exchange losses, real-estate-related costs and other specified adjustments.

The margin result shows the advantage of CME’s relatively fixed-cost model during periods of rising volumes. However, licensing expense remains a variable cost that can limit incremental margin expansion when equity products lead activity.

Demand, Customers and Pricing

Open interest reached 128M contracts at quarter-end and exceeded 133M contracts in October, according to management. Open interest reflects outstanding positions held on CME’s markets and is an important indicator of client risk-management activity, although it does not directly translate into near-term transaction revenue.

Management also highlighted more than $100B in average daily margin savings for customers during the quarter. The savings are generated through portfolio-margining and cross-margin arrangements across CME’s futures, options, swaps and cash-market products.

In rates, average daily savings from portfolio margining in the swaps business reached $13.2B in September, up 58% from September 2025. CME’s cross-margining arrangement with Fixed Income Clearing Corporation generated average daily savings of $2.3B in September, with 24 clearing members registered for the program.

Equity-related capital efficiencies were also substantial, totaling nearly $47B during the quarter. Management said roughly 60% of the increase in equity margin savings this year came from new positions established at CME, with the remaining 40% tied to higher index levels and associated margin balances.

CME introduced pricing changes on Oct. 1 affecting crypto, grains, interest-rate tiers and micro equity products. Management expects the changes to add approximately 0.5% to 1% to clearing and transaction fee revenue on an annualized basis. The company has moved away from a single annual pricing freeze, instead adjusting pricing at points when it believes market conditions or product value warrant changes.

What is CME Group’s outlook for Q4 2026?

CME did not issue formal financial guidance. Management said fourth-quarter average daily volume was running 17% ahead of the prior year’s record fourth quarter as of the earnings call, while year-to-date volume was tracking 12% above the prior-year period.

Several product and infrastructure milestones could affect longer-term growth. CME expects to launch CME Securities Clearing on Dec. 7, positioning the company for the SEC’s Treasury clearing mandate. Treasury Link, which allows centralized spread trading between Treasury futures and BrokerTec cash Treasuries, is in testing and is intended to reduce execution and legging risk for clients trading across the two markets.

Management also said it expects to begin migrating its primary Chicago markets to Google Cloud in late 2027. The Dallas disaster-recovery facility has been available for client testing since June, with management saying latency and consistency have been as good as or better than the existing on-premises offering. CME has therefore decided not to relocate its livestock markets to Dallas in the interim.

New products remain an additional, but still early-stage, source of opportunity. Single Stock futures have traded more than 350,000 contracts and $3.5B in notional value since launch. CME is also awaiting regulatory review of its proposed Compute Futures products, which are intended to provide hedging tools related to AI and data-center computing costs. Management characterized client interest as significant, but timing remains dependent on regulatory action.

Balance Sheet, Cash Flow and Capital

CME ended the quarter with $2.2B of cash and cash equivalents, plus $225M deposited with Fixed Income Clearing Corporation and included in other current assets. Total debt was $3.4B, essentially unchanged from $3.4B at year-end.

The decline in cash from $4.4B at Dec. 31 reflects, among other factors, the company’s capital returns. CME returned nearly $1B to shareholders during the quarter, including $465M in regular dividends and $524M in share repurchases.

Management said it has completed the repurchase deployment of proceeds related to OSTTRA. The company emphasized that its regular dividend, variable-dividend framework and repurchase capacity give it flexibility to return capital while retaining capacity for selective acquisitions or strategic investments.

CME’s debt level remains modest relative to its earnings base, supporting that flexibility. Management said it remains selective on acquisitions and would focus on opportunities that add clients, products or capital efficiencies rather than pursuing transactions simply to expand scale.

What Investors Should Watch

1. Volume durability after the volatility-driven quarter

The 16% increase in average daily volume powered the quarter. Investors should monitor whether CME can sustain growth across rates, equities, energy and commodities if market volatility moderates or central-bank policy uncertainty recedes.

2. Revenue per contract and pricing realization

Average revenue per contract declined year over year even as clearing revenue increased. The October pricing changes are expected to provide a modest annualized lift, but product mix, customer mix and incentive programs will remain important determinants of revenue conversion.

3. Market data growth quality

Market data is becoming a larger and highly profitable revenue stream, with 20% quarterly growth. Investors should distinguish subscriber and platform growth from audit recoveries and prior-period catch-up payments, which added $4.7M in the quarter.

4. Treasury clearing and cross-margin adoption

The Dec. 7 securities-clearing launch, Treasury Link testing and FICC cross-margin participation could strengthen CME’s rates ecosystem. The key evidence will be clearing-member adoption, client usage and the level of incremental margin savings delivered.

5. Product innovation versus execution and regulatory risk

Single Stock futures, 24/7 metals trading, Compute Futures and sports-related futures broaden CME’s product set. Their financial contribution remains early, while Compute Futures depends on regulatory approval and broader 24/7 expansion depends on clearing, banking and operational infrastructure.

AlgovestIQ Takeaway

CME delivered a strong quarter by the measures that matter most for an exchange operator: broad volume growth, rising transaction revenue, record market data revenue and margin expansion. The result was not dependent on a single product line, and the 16% increase in average daily volume across all six asset classes supports management’s view that global clients are using CME’s markets more intensively for risk management.

The quality of revenue growth was generally solid, although the decline in average revenue per contract shows that mix remains important. Stronger equity activity also raised licensing costs, illustrating that not every incremental dollar of trading revenue carries the same margin profile. Market data remains a valuable offset, but investors should account for the $4.7M audit and catch-up contribution when assessing its 20% growth rate.

CME’s strategic work is increasingly focused on expanding the value of its ecosystem rather than simply listing more contracts. Securities clearing, Treasury Link and cross-margining initiatives could deepen customer relationships and reinforce the company’s competitive position in rates and clearing. The more than $100B in daily customer margin savings is meaningful because it gives market participants an economic reason to concentrate activity on CME’s platforms.

The unresolved question is whether the current trading environment can support continued double-digit volume growth after a strong 2026. Management’s early fourth-quarter commentary was constructive, but transaction revenue remains exposed to changes in volatility, open interest, product mix and client activity.

The investment case would strengthen if CME sustains volume growth while maintaining pricing discipline, continues to expand market data subscriptions, and demonstrates meaningful adoption of Treasury clearing and cross-margining services. It would weaken if trading activity normalizes sharply, revenue per contract declines further, or technology and product investments fail to generate sufficient client adoption.

How did CME stock react?

CME closed at $295.79 on Oct 21, 2026, up 0.2% from $295.31 on Oct 20, 2026, the last close before the results were released.

SessionCloseChange
Oct 20, 2026 (before release)$295.31—
Oct 21, 2026$295.79+0.2%
Oct 22, 2026$305.98+3.6%

Closing prices from AlgovestIQ market data. A move around a report also reflects the wider market.

More from this earnings season

References

  1. Management commentary, analyst questions and outlook discussed on the call. Source: CME Group Q3 FY2026 earnings call transcript, as of Oct 21, 2026.
  2. Reported results, segment figures and guidance from the company's results announcement. Source: CME Group Form 8-K, Item 2.02 (SEC EDGAR), as of Oct 21, 2026.
  3. Reported revenue and EPS against analyst estimates, and the reported quarterly series. Source: AlgovestIQ reported-results data, as of Oct 21, 2026.

AI-generated analysis based on company-reported earnings data and earnings-call materials. Not investment advice.